Try

Ascendis Pharma A/S Ordinary Share

ASNDUnited States

25 filed reports · 383 financial concepts · 2 earnings calls · 0 media appearances

Filed reports

25 reports · Dec 2017 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 595 interim figures.

Report typeReportsFactsPeriods
Interim · 6-KSEC EDGAR162,862Jun 2021 to Jun 2026
Annual · 20-FSEC EDGAR92,718Dec 2017 to Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q26-KJun 30, 2026Aug 13, 2026411Open
FY2026 Q16-KMar 31, 2026May 7, 2026268Open
FY202520-FDec 31, 2025Feb 11, 2026730Open
FY2025 Q36-KSep 30, 2025Nov 12, 2025280Open
FY2025 Q26-KJun 30, 2025Aug 7, 2025183Open
FY2025 Q16-KMar 31, 2025May 1, 2025143Open
FY202420-FDec 31, 2024Feb 12, 2025359Open
FY2024 Q36-KSep 30, 2024Nov 14, 2024131Open
FY2024 Q26-KJun 30, 2024Sep 3, 2024125Open
FY2024 Q16-KMar 31, 2024May 2, 2024169Open
FY202320-FDec 31, 2023Feb 7, 2024339Open
FY2023 Q36-KSep 30, 2023Nov 7, 2023145Open

Financial data

383 concepts · 5,580 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial382 concepts · 5,354 facts · Dec 2013 to Jun 2026

  • Revenue63 · Dec 2015 to Jun 2026
  • Cash and cash equivalents43 · Dec 2014 to Jun 2026
  • Equity43 · Dec 2014 to Jun 2026
  • Lease liabilities43 · Dec 2018 to Mar 2026
  • Number of shares issued40 · Dec 2013 to Jun 2026
  • Assets (IFRS)36 · Dec 2016 to Jun 2026
  • Comprehensive income36 · Dec 2015 to Jun 2026
  • Comprehensive income attributable to owners of parent (IFRS)36 · Dec 2015 to Jun 2026
  • Current assets36 · Dec 2016 to Jun 2026
  • Current liabilities36 · Dec 2016 to Jun 2026
  • Current prepayments36 · Dec 2016 to Jun 2026
  • Current tax liabilities (IFRS)36 · Dec 2016 to Jun 2026
  • Current trade receivables36 · Dec 2016 to Jun 2026
  • Distributable equity36 · Dec 2016 to Jun 2026
  • Equity and liabilities36 · Dec 2016 to Jun 2026
  • Finance costs36 · Dec 2015 to Jun 2026
  • Finance income (IFRS)36 · Dec 2015 to Jun 2026
  • Issued capital36 · Dec 2016 to Jun 2026
  • Liabilities (IFRS)36 · Dec 2016 to Jun 2026
  • Noncurrent assets (IFRS)36 · Dec 2016 to Jun 2026
  • Other comprehensive income net of tax exchange differences on translation36 · Dec 2015 to Jun 2026
  • Other comprehensive income that will be reclassified to profit or loss net of tax36 · Dec 2015 to Jun 2026
  • Other current receivables36 · Dec 2016 to Jun 2026
  • Profit loss before tax36 · Dec 2015 to Jun 2026

Geography1 concepts · 226 facts · Dec 2015 to Jun 2026

  • Revenue226 · Dec 2015 to Jun 2026

Segments

226 facts

Figures broken down by business line, region, product or another axis the company reports on.

Geographical areas17 members · 226 facts

  • North America31 · Dec 2016 to Sep 2025
  • Europe25 · Mar 2021 to Jun 2026
  • Europe24 · Mar 2021 to Jun 2026
  • North america24 · Jun 2020 to Sep 2025
  • CN16 · Dec 2019 to Jun 2023
  • Rest Of World16 · Dec 2022 to Jun 2026
  • Rest of world15 · Sep 2023 to Jun 2026
  • Dk14 · Mar 2024 to Jun 2026
  • DK13 · Dec 2023 to Jun 2026
  • Cn12 · Jun 2020 to Jun 2023
  • Asia11 · Dec 2021 to Jun 2024
  • US10 · Dec 2015 to Jun 2026
  • Us6 · Mar 2025 to Jun 2026
  • Asia6 · Sep 2022 to Jun 2024
  • CH1 · Dec 2015
  • Country Of Domicile1 · Dec 2018
  • DE1 · Dec 2015

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Management discussion (MD&A) commentary33 claims from 2 reports · Dec 2024 to Dec 2025
  • Risk-factor changes16 claims from 1 reports · Dec 2025
  • Risk factors192 risks from 2 annual reports · 2024 to 2025

Earnings calls

2 calls · May 2026 to Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Aug 12, 2026
  • FY2026 Q1May 7, 2026

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Ascendis Pharma A/S Ordinary Share (ASND) data · FactIQ